Skip to main content
Premium Trial:

Request an Annual Quote

Bioneer Supplying Emory Genetics Lab with PCR Kits


Bioneer, the US subsidiary of South Korea's Bioneer Corporation, said recently that it has signed a contract to provide PCR kits to Emory Genetics Laboratory, an Emory University-affiliated provider of clinical and laboratory genetic services.

Under the contract, Alameda, Calif.-based Bioneer will supply Emory Genetics Laboratory with AccuPower PyroHotStart PCR kits, which use the company's exclusive PyroHotStart technology. The company expects to supply the laboratory with about 500,000 tests, which may increase by up to 50 percent in the second year.

In addition, Emory Genetics Laboratory will work with Bioneer to provide technical validation and references that may be used as proof sources for other labs, Bioneer said. The contract will be automatically extended on an annual basis, and may change as volumes increase.

According to the company, its AccuPower kits include all necessary reagents and materials lyophilized in individual PCR tubes. Reactions are set up by adding purified nucleic acids, primers, and distilled water to the tubes.

Bioneer said that this procedure reduces setup time and prevents carryover contamination that can occur with standard PCR methods, making the kit suitable for diagnostics and research.

Korea's Bioneer, headquartered in Daejeon, trades publicly on the Kosdaq. Besides its California-based US subsidiary, the company has branches in China and Australia. The company's product portfolio includes real-time PCR diagnostic workstations, automated nucleic acid extraction systems, and diagnostic and sample prep kits.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.